{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:55:45Z","timestamp":1784098545766,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12020-021-02785-z","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T19:07:53Z","timestamp":1623352073000},"page":"1-4","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pituitary adenoma\u2026nomen omen?"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-3398","authenticated-orcid":false,"given":"Andrea","family":"Giustina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"2785_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"MBS Lopes","year":"2017","unstructured":"M.B.S. Lopes, The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol. 134, 521\u2013535 (2017)","journal-title":"Acta Neuropathol."},{"key":"2785_CR2","doi-asserted-by":"publisher","first-page":"C5","DOI":"10.1530\/ERC-17-0004","volume":"24","author":"SL Asa","year":"2017","unstructured":"S.L. Asa, O. Casar-Borota, P. Chanson, E. Delgrange, P. Earls, S. Ezzat, A. Grossman, H. Ikeda, N. Inoshita, N. Karavitaki, M. Korbonits, E.R. Laws Jr., M.B. Lopes, N. Maartens, I.E. McCutcheon, O. Mete, H. Nishioka, G. Raverot, F. Roncaroli, W. Saeger, L.V. Syro, A. Vasiljevic, C. Villa, A. Wierinckx, J. Trouillas, From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. Endocr. Relat. Cancer 24, C5\u2013C8 (2017). attendees of 14th Meeting of the International Pituitary Pathology Club AFN","journal-title":"Endocr. Relat. Cancer"},{"key":"2785_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11102-019-00988-2","volume":"22","author":"KKY Ho","year":"2019","unstructured":"K.K.Y. Ho, M. Fleseriu, J. Wass, A. van der Lely, A. Barkan, A. Giustina, F.F. Casanueva, A.P. Heaney, N. Biermasz, C. Strasburger, S. Melmed, A tale of pituitary adenomas: to NET or not to NET: Pituitary Society position statement. Pituitary 22, 569\u2013573 (2019)","journal-title":"Pituitary"},{"key":"2785_CR4","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s11102-019-01015-0","volume":"23","author":"SL Asa","year":"2020","unstructured":"S.L. Asa, S. Asioli, S. Bozkurt, O. Casar-Borota, L. Chinezu, N. Comunoglu, G. Cossu, M. Cusimano, E. Delgrange, P. Earls, S. Ezzat, N. Gazioglu, A. Grossman, F. Guaraldi, R.A. Hickman, H. Ikeda, M.L. Jaffrain-Rea, N. Karavitaki, I. Kraljevic, S. La Rosa, E. Manojlovic-Gacic, N. Maartens, I.E. McCutcheon, M. Messerer, O. Mete, H. Nishioka, B. Oz, S. Pakbaz, M. Pekmezci, A. Perry, L. Reiniger, F. Roncaroli, W. Saeger, F. Soylemezoglu, O. Tachibana, J. Trouillas, J. Turchini, S. Uccella, C. Villa, S. Yamada, S. Yarman, Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution. Pituitary 23, 322\u2013325 (2020)","journal-title":"Pituitary"},{"key":"2785_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11102-019-01027-w","volume":"23","author":"KKY Ho","year":"2020","unstructured":"K.K.Y. Ho, M. Fleseriu, J. Wass, A. van der Lely, A. Barkan, A. Giustina, F.F. Casanueva, A.P. Heaney, N. Biermasz, C. Strasburger, S. Melmed, The tale in evolution: clarity, 21 consistency and consultation, not contradiction and confusion. Pituitary 23, 476\u2013477 (2020)","journal-title":"Pituitary"},{"issue":"3","key":"2785_CR6","doi-asserted-by":"publisher","first-page":"bvaa205","DOI":"10.1210\/jendso\/bvaa205","volume":"5","author":"K Ho","year":"2021","unstructured":"K. Ho, M. Fleseriu, U. Kaiser, R. Salvatori, T. Brue, M.B. Lopes, P. Kunz, M. Molitch, S.A. Camper, M. Gadelha, L.V. Syro, E. Laws, M. Reincke, H. Nishioka, A. Grossman, A. Barkan, F. Casanueva, J. Wass, A. Mamelak, L. Katznelson, A.J. van der Lely, S. Radovick, M. Bidlingmaier, M. Boguszewski, J. Bollerslev, A.R. Hoffman, N. Oyesiku, G. Raverot, A. Ben-Shlomo, R. Fowkes, I. Shimon, H. Fukuoka, A.M. Pereira, Y. Greenman, A.P. Heaney, M. Gurnell, G. Johannsson, R.Y. Osamura, M. Buchfelder, M.C. Zatelli, M. Korbonits, P. Chanson, N. Biermasz, D.R. Clemmons, N. Karavitaki, M.D. Bronstein, P. Trainer, S. Melmed, Pituitary Neoplasm Nomenclature Workshop: does adenoma stand the test of time? J. Endocr. Soc. 5(3), bvaa205 (2021). https:\/\/doi.org\/10.1210\/jendso\/bvaa205","journal-title":"J. Endocr. Soc."},{"issue":"4","key":"2785_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","volume":"21","author":"A Giustina","year":"2020","unstructured":"A. Giustina, G. Barkhoudarian, A. Beckers, A. Ben-Shlomo, N. Biermasz, B. Biller, C. Boguszewski, M. Bolanowski, J. Bollerslev, V. Bonert, M.D. Bronstein, M. Buchfelder, F. Casanueva, P. Chanson, D. Clemmons, M. Fleseriu, A.M. Formenti, P. Freda, M. Gadelha, E. Geer, M. Gurnell, A.P. Heaney, K.K.Y. Ho, A.G. Ioachimescu, S. Lamberts, E. Laws, M. Losa, P. Maffei, A. Mamelak, M. Mercado, M. Molitch, P. Mortini, A.M. Pereira, S. Petersenn, K. Post, M. Puig-Domingo, R. Salvatori, S.L. Samson, I. Shimon, C. Strasburger, B. Swearingen, P. Trainer, M.L. Vance, J. Wass, M.E. Wierman, K.C.J. Yuen, M.C. Zatelli, S. Melmed, Multidisciplinary management of acromegaly: a consensus. Rev. Endocr. Metab. Disord. 21(4), 667\u2013678 (2020). https:\/\/doi.org\/10.1007\/s11154-020-09588-z","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"4","key":"2785_CR8","doi-asserted-by":"publisher","first-page":"dgz096","DOI":"10.1210\/clinem\/dgz096","volume":"105","author":"A Giustina","year":"2020","unstructured":"A. Giustina, A. Barkan, A. Beckers, N. Biermasz, B.M.K. Biller, C. Boguszewski, M. Bolanowski, V. Bonert, M.D. Bronstein, F.F. Casanueva, D. Clemmons, A. Colao, D. Ferone, M. Fleseriu, S. Frara, M.R. Gadelha, E. Ghigo, M. Gurnell, A.P. Heaney, K. Ho, A. Ioachimescu, L. Katznelson, F. Kelestimur, J. Kopchick, M. Krsek, S. Lamberts, M. Losa, A. Luger, P. Maffei, M. Marazuela, G. Mazziotti, M. Mercado, P. Mortini, S. Neggers, A.M. Pereira, S. Petersenn, M. Puig-Domingo, R. Salvatori, I. Shimon, C. Strasburger, S. Tsagarakis, A.J. van der Lely, J. Wass, M.C. Zatelli, S. Melmed, A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J. Clin. Endocrinol. Metab. 105(4), dgz096 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgz096","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"2785_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11154-020-09564-7","volume":"21","author":"P Mortini","year":"2020","unstructured":"P. Mortini, G. Nocera, F. Roncelli, M. Losa, A.M. Formenti, A. Giustina, The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): a surgical perspective. Rev. Endocr. Metab. Disord. 21(4), 527\u2013536 (2020). https:\/\/doi.org\/10.1007\/s11154-020-09564-7","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"1","key":"2785_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ecl.2007.10.013","volume":"37","author":"T Mancini","year":"2008","unstructured":"T. Mancini, F.F. Casanueva, A. Giustina, Hyperprolactinemia and prolactinomas. Endocrinol. Metab. Clin. North Am. 37(1), 67\u201399, viii (2008). https:\/\/doi.org\/10.1016\/j.ecl.2007.10.013","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"3","key":"2785_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ecl.2020.05.010","volume":"49","author":"S Frara","year":"2020","unstructured":"S. Frara, G. Rodriguez-Carnero, A.M. Formenti, M.A. Martinez-Olmos, A. Giustina, F.F. Casanueva, Pituitary tumors centers of excellence. Endocrinol. Metab. Clin. North Am. 49(3), 553\u2013564 (2020). https:\/\/doi.org\/10.1016\/j.ecl.2020.05.010","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"2785_CR12","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","volume":"382","author":"S Melmed","year":"2020","unstructured":"S. Melmed, Pituitary-tumor endocrinopathies. N. Engl. J. Med. 382, 937\u2013950 (2020)","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"2785_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11102-019-00977-5","volume":"22","author":"A Giustina","year":"2019","unstructured":"A. Giustina, M.D. Bronstein, P. Chanson, S. Petersenn, F.F. Casanueva, C. Sert, A. Houchard, S. Melmed, Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT\u00ae validation study. Pituitary 22(5), 476\u2013487 (2019). https:\/\/doi.org\/10.1007\/s11102-019-00977-5","journal-title":"Pituitary"},{"issue":"6","key":"2785_CR14","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1210\/jc.2008-1337","volume":"94","author":"A Bianchi","year":"2009","unstructured":"A. Bianchi, A. Giustina, V. Cimino, R. Pola, F. Angelini, A. Pontecorvi, De, L. Marinis, Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. J. Clin. Endocrinol. Metab. 94(6), 2015\u20132022 (2009). https:\/\/doi.org\/10.1210\/jc.2008-1337","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"2785_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1701\/2332.25074","volume":"107","author":"A Giustina","year":"2016","unstructured":"A. Giustina, Acromegalia: ridurre il ritardo della diagnosi [Acromegaly: reducing diagnostic delay]. Recent. Prog. Med. 107(8), 450\u2013451 (2016). https:\/\/doi.org\/10.1701\/2332.25074","journal-title":"Recent. Prog. Med."},{"issue":"9","key":"2785_CR16","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","volume":"14","author":"S Melmed","year":"2018","unstructured":"S. Melmed, M.D. Bronstein, P. Chanson, A. Klibanski, F.F. Casanueva, J.A.H. Wass, C.J. Strasburger, A. Luger, D.R. Clemmons, A. Giustina, A Consensus Statement on acromegaly therapeutic outcomes. Nat. Rev. Endocrinol. 14(9), 552\u2013561 (2018). https:\/\/doi.org\/10.1038\/s41574-018-0058-5","journal-title":"Nat. Rev. Endocrinol."},{"key":"2785_CR17","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0796","volume":"178","author":"G Raverot","year":"2018","unstructured":"G. Raverot, P. Burman, A. McCormack, A. Heaney, S. Petersenn, V. Popovic, J. Trouillas, O.M. Dekkers, European Society of Endocrinology clinical 26 practice guidelines for the management of aggressive pituitary tumours and carcinomas. Eur. J. Endocrinol. 178, G1\u2013G24 (2018)","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"2785_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11102-010-0269-9","volume":"14","author":"A Giustina","year":"2011","unstructured":"A. Giustina, M.D. Bronstein, F.F. Casanueva, P. Chanson, E. Ghigo, K.K. Ho, A. Klibanski, S. Lamberts, P. Trainer, S. Melmed, Current management practices for acromegaly: an international survey. Pituitary 14(2), 125\u2013133 (2011). https:\/\/doi.org\/10.1007\/s11102-010-0269-9","journal-title":"Pituitary"},{"issue":"5","key":"2785_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11102-017-0838-2","volume":"20","author":"FF Casanueva","year":"2017","unstructured":"F.F. Casanueva, A.L. Barkan, M. Buchfelder, A. Klibanski, E.R. Laws, J.S. Loeffler, S. Melmed, P. Mortini, J. Wass, A. Giustina, Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): a Pituitary Society statement. Pituitary 20(5), 489\u2013498 (2017). https:\/\/doi.org\/10.1007\/s11102-017-0838-2","journal-title":"Pituitary"},{"key":"2785_CR20","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3171\/2010.8.JNS10290","volume":"114","author":"G Zada","year":"2011","unstructured":"G. Zada, W.W. Woodmansee, S. Ramkissoon, J. Amadio, V. Nose, E.R. Laws Jr, Atypical pituitary adenomas: incidence, clinical characteristics, and implications. J. Neurosurg. 114, 336\u2013344 (2011)","journal-title":"J. Neurosurg."},{"key":"2785_CR21","first-page":"610","volume":"33","author":"E Knosp","year":"1993","unstructured":"E. Knosp, E. Steiner, K. Kitz, C. Matula, Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33, 610\u2013618 (1993)","journal-title":"Neurosurgery"},{"key":"2785_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3171\/jns.2002.96.2.0195","volume":"96","author":"BP Meij","year":"2002","unstructured":"B.P. Meij, M.B. Lopes, D.B. Ellegala, T.D. Alden, E.R. Laws Jr., The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J. Neurosurg. 96, 195\u2013208 (2002)","journal-title":"J. Neurosurg."},{"issue":"7","key":"2785_CR23","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1210\/jc.2008-0126","volume":"93","author":"A Fusco","year":"2008","unstructured":"A. Fusco, M.C. Zatelli, A. Bianchi, V. Cimino, L. Tilaro, F. Veltri, F. Angelini, L. Lauriola, V. Vellone, F. Doglietto, M.R. Ambrosio, G. Maira, A. Giustina, E.C. degli Uberti, A. Pontecorvi, L. De Marinis, Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas. J. Clin. Endocrinol. Metab. 93(7), 2746\u20132750 (2008). https:\/\/doi.org\/10.1210\/jc.2008-0126","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2785_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1530\/EJE-20-0767","volume":"184","author":"S Chiloiro","year":"2021","unstructured":"S. Chiloiro, A. Giampietro, F. Mirra, F. Donfrancesco, T. Tartaglione, P.P. Mattogno, F. Angelini, L. Liverana, M. Gessi, A. Carmelo, G. Rindi, A. Giustina, M. Fleseriu, A. Pontecorvi, L. De Marinis, Bianchi A. Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response. Eur. J. Endocrinol. 184(2), 217\u2013229 (2021). https:\/\/doi.org\/10.1530\/EJE-20-0767","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"2785_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11102-021-01148-1","volume":"24","author":"S Frara","year":"2021","unstructured":"S. Frara, A. Allora, L. Castellino, L. di Filippo, P. Loli, A. Giustina, COVID-19 and the pituitary. Pituitary 24(3), 465\u2013481 (2021). https:\/\/doi.org\/10.1007\/s11102-021-01148-1","journal-title":"Pituitary"},{"key":"2785_CR26","doi-asserted-by":"publisher","unstructured":"A. Giustina, E. Legg, B.M. Cesana, S. Frara, P. Mortini, M. Fleseriu,, Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era. Endocrine 71(2), 273\u2013280 (2021). https:\/\/doi.org\/10.1007\/s12020-020-02565-1. Erratum in: Endocrine. 2021 May;72(2):596","DOI":"10.1007\/s12020-020-02565-1"},{"issue":"2","key":"2785_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12020-021-02734-w","volume":"72","author":"M Puig-Domingo","year":"2021","unstructured":"M. Puig-Domingo, M. Marazuela, B.O. Yildiz, A. Giustina, COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology. Endocrine 72(2), 301\u2013316 (2021). https:\/\/doi.org\/10.1007\/s12020-021-02734-w","journal-title":"Endocrine"},{"issue":"16","key":"2785_CR28","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1080\/14656566.2017.1391217","volume":"18","author":"G Mazziotti","year":"2017","unstructured":"G. Mazziotti, A. Mosca, S. Frara, G. Vitale, A. Giustina, Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects. Exp. Opin. Pharmacother. 18(16), 1679\u20131689 (2017). https:\/\/doi.org\/10.1080\/14656566.2017.1391217","journal-title":"Exp. Opin. Pharmacother."},{"issue":"1","key":"2785_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/BF03349183","volume":"29","author":"M Gola","year":"2006","unstructured":"M. Gola, S. Bonadonna, G. Mazziotti, G. Amato, A. Giustina, Resistance to somatostatin analogs in acromegaly: an evolving concept? J. Endocrinol. Invest. 29(1), 86\u201393 (2006). https:\/\/doi.org\/10.1007\/BF03349183","journal-title":"J. Endocrinol. Invest."},{"issue":"5","key":"2785_CR30","doi-asserted-by":"publisher","first-page":"e36411","DOI":"10.1371\/journal.pone.0036411","volume":"7","author":"A Giustina","year":"2012","unstructured":"A. Giustina, G. Mazziotti, V. Torri, M. Spinello, I. Floriani, S. Melmed, Meta-analysis on the effects of octreotide on tumor mass in acromegaly. PLoS ONE 7(5), e36411 (2012). https:\/\/doi.org\/10.1371\/journal.pone.0036411","journal-title":"PLoS ONE"},{"key":"2785_CR31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","volume":"126","author":"J Trouillas","year":"2013","unstructured":"J. Trouillas, P. Roy, N. Sturm, E. Dantony, C. Cortet-Rudelli, G. Viennet, J.F. Bonneville, R. Assaker, C. Auger, T. Brue, A. Cornelius, H. Dufour, E. Jouanneau, P. Francois, F. Galland, F. Mougel, F. Chapuis, L. Villeneuve, C.A. Maurage, D. Figarella-Branger, G. Raverot, A. Barlier, M. Bernier, F. Bonnet, F. Borson-Chazot, G. Brassier, S. Caulet-Maugendre, O. Chabre, P. Chanson, J.F. Cottier, B. Delemer, E. Delgrange, L. Di Tommaso, S. Eimer, S. Gaillard, M. Jan, J.J. Girard, V. Lapras, H. Loiseau, J.G. Passagia, M. Patey, A. Penfornis, J.Y. Poirier, G. Perrin, A. Tabarin, A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol. 126, 123\u2013135 (2013)","journal-title":"Acta Neuropathol."},{"key":"2785_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/EJE-18-0749","volume":"180","author":"S Asioli","year":"2019","unstructured":"S. Asioli, A. Righi, M. Iommi, C. Baldovini, F. Ambrosi, F. Guaraldi, M. Zoli, D. Mazzatenta, M. Faustini-Fustini, P. Rucci, C. Giannini, M.P. Foschini, Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre. Eur. J. Endocrinol. 180, 127\u2013134 (2019)","journal-title":"Eur. J. Endocrinol."},{"key":"2785_CR33","doi-asserted-by":"publisher","unstructured":"Chiloiro S., De Marinis L. From pituitary adenoma to pituitary neuroendocrine tumors: how molecular pathways may impact on the therapeutic management? Endocr., Metab. Immune Disord.\u2014Drug Targets. https:\/\/doi.org\/10.2174\/1871530321666210226152901","DOI":"10.2174\/1871530321666210226152901"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02785-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02785-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02785-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T09:32:22Z","timestamp":1631611942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02785-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["2785"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02785-z","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"assertion":[{"value":"7 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No sources of funding, financial or nonfinancial interests are declared. Due to the nature of the article (viewpoint) no study-specific approval by the appropriate ethics committee for research involving humans and\/or animals, neither informed consent if the research involved human participants, and a statement on the welfare of animals if the research involved animals is provided.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}